Who is sponsoring NCT03243513?

NCT03243513 is sponsored by University of New Mexico.

What drugs are being tested in NCT03243513?

Interventions in NCT03243513: Retrospective Chart Review.

What condition does NCT03243513 study?

NCT03243513 studies Pregnancy Termination.

Is NCT03243513 still recruiting?

NCT03243513 is currently terminated. Last updated 12 January 2024.

Last reviewed 2024-01-12 · How we verify

NCT03243513

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Abo Follow-up Study

Terminated Last updated 12 January 2024

What this trial tests

trial testing Retrospective Chart Review in Pregnancy Termination in 1,600 participants. Terminated before completion.

Timeline

4 August 2017

Primary endpoint
28 February 2020

28 February 2020

Quick facts

Lead sponsor	University of New Mexico
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	1,600
Start date	4 August 2017
Primary completion	28 February 2020
Estimated completion	28 February 2020
Sites	1 location across United States

Drugs / interventions tested

Retrospective Chart Review

Conditions studied

Pregnancy Termination — all drugs for Pregnancy Termination →

Sponsor

University of New Mexico

Who can join

Eligibility, female only, with Pregnancy Termination. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the project is to identify an efficient and effective policy or procedure for identifying complications from surgical abortions through follow-up phone calls.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Retrospective Chart Review

Trials testing the same drug.

NCT03579108 — Hypertension Management in Family Practice · unknown
NCT03576560 — Selective Use of Antibiotics in Neonates Born to Mothers With Suspected Chorioamnionitis · completed
NCT02502396 — Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensiv · completed

Other University of New Mexico trials

Trials by the same sponsor.

NCT07484906 — Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies · Phase 2 · withdrawn
NCT07506395 — Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder · Phase 1 · not yet recruiting
NCT07265973 — PREPARE: Perioperative REhabilitation Around Vaginal Prolapse RepAir Surgery for Recovery Enhancement · NA · recruiting
NCT06982443 — Wellness, Alcohol, Vitals, and Emotions · NA · recruiting
NCT06940609 — Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03243513 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of New Mexico
Last refreshed: 12 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03243513.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing